Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

TIGLUTIK (Riluzole) for the Treatment of Amyotrophic Lateral Sclerosis

Drug Name

TIGLUTIK™ (Riluzole)

Developer

ITF Pharma

Therapy Class

Nootropic and neuroprotective agent

Current Indication

Amyotrophic lateral sclerosis

Market Sector

Central nervous system

Development Status

Approved in the US
Expand

Go Top